EGFRvIII-DICE

N/A

Report date: 2026/03/19 16:58:35

Base Information

Drug NameEGFRvIII-DICE
Drug Alias Nameanti-CD3/anti-EGFRvIII DNA-encoded immune cell engager (Inovio Pharmaceuticals/Wistar Institute)Anti-CD3/Anti-EGFRvIII Bispecific T-Cell Engager (Inovio Pharmaceuticals/Wistar Institute)
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Bispecific monoclonal antibodyBiologics > T cell engagers
Mechanisms of ActionT cell surface glycoprotein CD3 modulatorsEpidermal growth factor receptor erbB1 modulators
TargetsT cell surface glycoprotein CD3Epidermal growth factor receptor erbB1
Therapy Area/IndicationsGlioblastoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesThe Wistar Institute Of Anatomy And Biology
China Registration ClassN/A

Develop Information

Active CompaniesInovio Pharmaceuticals IncThe Wistar Institute Of Anatomy And Biology
Inactive CompaniesN/A
Active IndicationsGlioblastoma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A